27 related articles for article (PubMed ID: 25545549)
1. Low drug load, high retention mometasone furoate cream with polyglyceryl - 3 oleate as a chemical enhancer: Formulation development, in vivo and in vitro evaluation and molecular mechanisms.
Jia W; Pang Y; Zhao C; Cai Y; Zhang Y; Liu C; Fang L
Int J Pharm; 2024 Jun; 659():124284. PubMed ID: 38810934
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of self-made WenyangJianpi-qushi Decoction combined with mometasone furoate cream in the treatment of atopic dermatitis of spleen deficiency and dampness accumulation type.
Tan J; Fan Y; Liu L; Deng L; Li X; Lan L; Zeng Y
Cutan Ocul Toxicol; 2024 May; ():1-5. PubMed ID: 38781033
[No Abstract] [Full Text] [Related]
3. Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma.
Chapman KR; Watz H; Singh D; Hohlfeld JM; Diamant Z; Jones I; Tillmann HC; Nikolaev I
Clin Drug Investig; 2021 May; 41(5):489-492. PubMed ID: 33864631
[No Abstract] [Full Text] [Related]
4. Autophagy is the key to making chronic wounds acute in skin wound healing.
Mijaljica D; Spada F; Klionsky DJ; Harrison IP
Autophagy; 2023 Sep; 19(9):2578-2584. PubMed ID: 36994997
[TBL] [Abstract][Full Text] [Related]
5. Hydrogels for Atopic Dermatitis and Wound Management: A Superior Drug Delivery Vehicle.
Harrison IP; Spada F
Pharmaceutics; 2018 Jun; 10(2):. PubMed ID: 29899219
[TBL] [Abstract][Full Text] [Related]
6. Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids.
Spada F; Barnes TM; Greive KA
Australas J Dermatol; 2018 Aug; 59(3):e168-e174. PubMed ID: 29411351
[TBL] [Abstract][Full Text] [Related]
7. Mometasone furoate nasal spray for the treatment of asthma.
Meteran H; Backer V
Expert Opin Investig Drugs; 2016 Aug; 25(8):999-1004. PubMed ID: 27218300
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence of 0.1% mometasone furoate lotion to 0.1% mometasone furoate hydrogel.
Greive KA; Barnes TM
Australas J Dermatol; 2016 May; 57(2):e39-45. PubMed ID: 25545549
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability, antipsoriatic efficacy and tolerability of a new light cream with mometasone furoate 0.1%.
Korting HC; Schöllmann C; Willers C; Wigger-Alberti W
Skin Pharmacol Physiol; 2012; 25(3):133-41. PubMed ID: 22353786
[TBL] [Abstract][Full Text] [Related]
10. Topical safety and vasoconstrictive assay-based bioequivalence of a new reformulated mometasone cream.
Krishna R; Horowitz A; Larson P; Bolognese J; Marcantonio EE
Drug Dev Ind Pharm; 2017 Jul; 43(7):1173-1177. PubMed ID: 28277845
[TBL] [Abstract][Full Text] [Related]
11. Transepidermal water loss (TEWL) and corneometry with hydrogel vehicle in the treatment of atopic dermatitis: a randomized, investigator-blind pilot study.
Kircik LH
J Drugs Dermatol; 2012 Feb; 11(2):180-4. PubMed ID: 22270199
[TBL] [Abstract][Full Text] [Related]
12. Halobetasol Propionate Lotion, 0.05% Provides Superior Hydration Compared to Halobetasol Propionate Cream, 0.05% in a Double-Blinded Study of Occlusivity and Hydration.
Grove G; Zerweck C; Houser T; Andrasfay A; Gauthier B; Holland C; Piacquadio D
J Drugs Dermatol; 2017 Feb; 16(2):140-144. PubMed ID: 28300856
[TBL] [Abstract][Full Text] [Related]
13. Increased bioavailability of hydrocortisone dissolved in a cream base.
Greive KA; Barnes TM
Australas J Dermatol; 2015 May; 56(2):e30-4. PubMed ID: 24372079
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
